Volume 76, Issue 1, Pages (July 2009)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

Thomas G. Pickering, MD, DPhil, William B. White, MD 
Nina Vasavada, Rajiv Agarwal  Kidney International 
Volume 56, Issue 1, Pages (July 1969)
Volume 54, Issue 2, Pages (August 1998)
Plasma sodium and hypertension
Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients  Maurizio Postorino, Carmen.
Volume 12, Issue 5, Pages (November 2010)
Volume 55, Issue 2, Pages (February 1999)
Prenatal exposure to nicotine modifies kidney weight and blood pressure in genetically susceptible rats: A case of gene-environment interaction  Zdenka.
Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.
Volume 54, Issue 2, Pages (August 1998)
Salt and Hypertension American Journal of Kidney Diseases
Joel D. Kopple, Xiaofei Zhu, Nancy L. Lew, Edmund G. Lowrie 
Kamyar Kalantar-Zadeh  Kidney International 
Volume 56, Issue 4, Pages (October 1999)
Homocysteine and risk in end-stage renal disease: a matter of context
George A. Kaysen, Burl R. Don
Volume 69, Issue 2, Pages (January 2006)
Prediction of hypertension in chronic hemodialysis patients
Volume 76, Issue 3, Pages (August 2009)
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Volume 74, Issue 3, Pages (August 2008)
The need for reliable serum parathyroid hormone measurements
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
Association between body mass index and risk of total knee replacement, the Singapore Chinese Health Study  Y.-Y. Leung, J.C. Allen, M. Noviani, L.-W.
Bradley A. Ford, Daniel W. Coyne, Charles S. Eby, Mitchell G. Scott 
Volume 74, Issue 9, Pages (November 2008)
Body size and outcomes on peritoneal dialysis in the United States
The calcium–phosphorus in guidelines for CKD-MBD
Blood pressure targets in hemodialysis patients
Volume 56, Issue 4, Pages (October 1999)
Volume 61, Issue 6, Pages (June 2002)
Response to ‘Hepcidin levels in patients with renal disease’
The dynamics of prognostic indicators: toward earlier identification of dialysis patients with a high risk of dying  Charles Chazot, Guillaume Jean  Kidney.
Volume 85, Issue 3, Pages (March 2014)
Volume 61, Issue 6, Pages (June 2002)
Erratum American Journal of Kidney Diseases
Volume 82, Issue 7, Pages (October 2012)
Proteinuria and hypertensive nephrosclerosis in African Americans
Cardiovascular disease in pediatric chronic dialysis patients
Volume 87, Issue 1, Pages (January 2015)
Volume 61, Issue 1, Pages (January 2002)
Transforming growth factor beta and progression of renal disease
Volume 73, Issue 8, Pages (April 2008)
Volume 79, Issue 1, Pages (January 2011)
Volume 58, Issue 1, Pages (July 2000)
Volume 64, Issue 2, Pages (August 2003)
Volume 71, Issue 9, Pages (May 2007)
The course of the remnant kidney model in mice
Nina Vasavada, Rajiv Agarwal  Kidney International 
Erratum American Journal of Kidney Diseases
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 10, Pages (November 2011)
Salt sensitivity in genetically hypertensive rats of the Lyon strain
Is it the low-protein diet or simply the salt restriction?
Volume 75, Issue 1, Pages (January 2009)
Volume 55, Issue 4, Pages (April 1999)
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Importance of blood pressure control in hemodialysis patient survival
Does an apple a day put hypertension in play?
James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon 
Membranous nephropathy: recent travels and new roads ahead
Volume 76, Issue 5, Pages (September 2009)
Wendy E. Hoy, Megan Rees, Emma Kile, John D. Mathews, Zhiqiang Wang 
Longitudinal relationships between diet-dependent renal acid load and blood pressure development in healthy children  Danika Krupp, Lijie Shi, Thomas.
Volume 75, Issue 8, Pages (April 2009)
Volume 80, Issue 4, Pages (August 2011)
Peter Stenvinkel, Olof Heimbürger, Catherine H. Tuck, Lars Berglund 
Presentation transcript:

Volume 76, Issue 1, Pages 72-80 (July 2009) Circulating transforming growth factor-β1 levels and the risk for kidney disease in African Americans  Manikkam Suthanthiran, Linda M. Gerber, Joseph E. Schwartz, Vijay K. Sharma, Mara Medeiros, RoseMerie Marion, Thomas G. Pickering, Phyllis August  Kidney International  Volume 76, Issue 1, Pages 72-80 (July 2009) DOI: 10.1038/ki.2009.66 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Bivariate relationship of peripheral blood transforming growth factor β1 protein concentration to plasma renin activity in black and white subjects. Peripheral blood total transforming growth factor β1 (TGF-β1, ng/ml) level was measured after acid activation and neutralization of serum and using an isoform-specific TGF-β1 ELISA. Plasma renin activity (PRA, ng/ml per h) was measured using an enzyme-based method and by quantification of generated Ang I by radioimmunoassay.22 Scatterplots show the bivariate relationship of TGF-β1 protein concentrations to PRA in black subjects (a) and white subjects (b). TGF-β1 protein measure was transformed using the square root transformation to reduce the positive skewness and make the resulting distribution approximately symmetric. PRA was transformed to natural logarithms (ln) to reduce skewness and heteroskedasticity. Pearson correlations (r) and their associated P-values are presented. The three boxes on the regression line show the predicted value of the outcome variable for subjects at the 10th, 50th, and 90th percentiles of the overall distribution of TGF-β1 protein. Numbers in parenthesis are the number of subjects studied. The symbols ‘o’ and ‘x’ are used to identify normotensive and hypertensive subjects. Kidney International 2009 76, 72-80DOI: (10.1038/ki.2009.66) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 2 Bivariate relationship of clinic systolic and diastolic blood pressure to peripheral blood TGF-β1 protein concentration in black and white subjects. Peripheral blood total transforming growth factor β1 (TGF-β1, ng/ml) level was measured after acid activation and neutralization of serum and using an isoform-specific TGF-β1 ELISA, and transformed using the square root transformation to reduce the positive skewness and make the resulting distribution approximately symmetric. Blood pressure measurements were made with a mercury column according to American Heart Association Guidelines, with patients in the seated position and arm at heart level.23 Three readings were obtained and their average was treated as the blood pressure measure. Scatterplots show the bivariate relationship of TGF-β1 protein concentrations to systolic (a and b) or diastolic (c and d) blood pressure. Pearson correlations (r) and their associated P-values are presented. The three boxes on the regression line show the predicted value of the outcome variable for subjects at the 10th, 50th, and 90th percentiles of the overall distribution of TGF-β1 protein. Numbers in parenthesis are the number of subjects studied. The symbols ‘o’ and ‘x’ are used to identify normotensive and hypertensive subjects. Kidney International 2009 76, 72-80DOI: (10.1038/ki.2009.66) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 3 Bivariate relationship of body mass index to peripheral blood TGF-β1 protein concentration in black and white subjects. Peripheral blood total transforming growth factor β1 (TGF-β1, ng/ml) level was measured after acid activation and neutralization of serum and using an isoform-specific TGF-β1 ELISA, and transformed using the square root transformation to reduce the positive skewness and make the resulting distribution approximately symmetric. Height and weight were measured two times. Body mass index (BMI) was calculated as average weight (kilograms) divided by the square of average height (meters). Scatterplots show the bivariate relationship of TGF-β1 protein concentrations to BMI in black subjects (a) and white subjects (b). Pearson correlations (r) and their associated P-values are presented. The three boxes on the regression line show the predicted BMI for subjects at the 10th, 50th, and 90th percentiles of the overall distribution of TGF-β1 protein. Numbers in parenthesis are the number of subjects studied. The symbols ‘o’ and ‘x’ are used to identify normotensive and hypertensive subjects. Kidney International 2009 76, 72-80DOI: (10.1038/ki.2009.66) Copyright © 2009 International Society of Nephrology Terms and Conditions